| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2023-06-01 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | $2.30M | $28.31M |
| Cost of Revenue | – | – | – | – | $0.00 | $433.00K |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – | – |
| R&D | $24.90M | $33.66M | $23.85M | – | $18.10M | $48.70M |
| SG&A | $12.81M | $11.33M | $11.90M | – | $14.64M | $18.49M |
| Operating Income | -$37.71M | -$44.99M | -$35.74M | – | -$39.62M | -$39.31M |
| Interest Expense | – | – | $1.06M | – | $3.60M | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | – | $11.00K | $0.00 |
| Net Income | -$39.57M | -$51.90M | -$35.20M | – | -$38.81M | -$54.57M |
| EPS (basic) | -2.5800 | -4.2500 | -6.9600 | – | -1.2900 | -1.9300 |
| EPS (diluted) | -2.5800 | -4.2500 | -6.9600 | – | -1.2900 | -1.9300 |
| Shares (diluted) | $15.31M | $12.20M | $5.06M | $9.70M | $30.04M | $28.24M |